Antisense therapeutics: is it as simple as complementary base recognition?
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (2) , 72-81
- https://doi.org/10.1016/s1357-4310(99)01638-x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α ExpressionJournal of Biological Chemistry, 1999
- Tetranucleotide GGGA Motif in Primary RNA TranscriptsPublished by Elsevier ,1998
- Pattern and Kinetics of Cytokine Production Following Administration of Phosphorothioate Oligonucleotides in MiceAntisense and Nucleic Acid Drug Development, 1997
- Mixed-Backbone Oligonucleotides Containing Phosphorothioate and Methylphosphonate Linkages as Second Generation Antisense OligonucleotideNucleosides and Nucleotides, 1997
- Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake, and hemolytic activity of oligonucleotidesBioorganic & Medicinal Chemistry Letters, 1996
- On the Quality Control of Antisense OligonucleotidesAntisense and Nucleic Acid Drug Development, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular MatrixPublished by Elsevier ,1995
- Oligonucleotide Sequences Required for Natural Killer Cell ActivationJapanese Journal of Cancer Research, 1992
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992